OCV Partners is a Los Angeles-based venture capital firm that invests in companies with differentiated technologies in compelling target markets. It focuses on technology (SaaS, FinTech, PropTech) and healthcare (Healthcare SaaS, Digital Health, MedTech, Biotech) sectors across seed to growth stages.
Average disclosed round size is $44.9M (across 17 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
20 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Rad AI | Series C | $60M | Jan 2025 |
 Orca AI | Series B | $23M | May 2024 |
| Rad AI | Series B | $50M | Apr 2024 |
 Ozette Technologies | Series A | $26M | Jul 2022 |
| Rad AI | Series A | $25M | Nov 2021 |
 ByHeart | Series B | — | Jul 2021 |
| Orca AI | Series A | $13M | Apr 2021 |
 Praxis Precision Medicines | Series C | $110M | Jul 2020 |
| ByHeart | Series A | $70M | Apr 2020 |
| FFigure8 | Series A | $40M | Aug 2019 |
 Museum of Ice Cream | Unknown | $40M | Aug 2019 |
 Invoice2go | Series A | $10M | Sep 2018 |
 Precision BioSciences | Series B | $110M | — |
 SafeBreach | Series D | $53.5M | — |
| SafeBreach | Series C | $19M | — |
 Finch Therapeutics | Growth | — | — |
 Ossio | Series C | $35M | — |
| FFinch Therapeutics Group | Growth | — | — |
| FFinch Therapeutics Group | Series C | $53M | — |
 Ozette | Series A | $26M | — |
Top Co-Investors
Kickstart Ventures3 shared
Cormorant Asset Management3 shared
Alexandria Venture Investments3 shared
Avenir Growth3 shared
SymBiosis3 shared
Willett Advisors3 shared
World Innovation Lab2 shared
Gradient Ventures2 shared
Khosla Ventures2 shared
Martin Ventures2 shared
Elizabeth Street Ventures2 shared
Maywic Select Investments2 shared
BECO Capital2 shared
D1 Capital Partners2 shared
Red Swan Ventures2 shared
Two River2 shared
Polaris Partners2 shared
Adage Capital Management2 shared
DNX Ventures2 shared
PayPal Ventures2 shared
Last updated: 8 September 2026